Hillstream BioPharma, Inc. (HILS) NASDAQ
0.24
+0.0127(+5.66%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.24
+0.0127(+5.66%)
Currency In USD
| Previous Close | 0.22 |
| Open | 0.23 |
| Day High | 0.24 |
| Day Low | 0.22 |
| 52-Week High | 2.65 |
| 52-Week Low | 0.17 |
| Volume | 313,195 |
| Average Volume | 684,778 |
| Market Cap | 4.17M |
| PE | -0.34 |
| EPS | -0.7 |
| Moving Average 50 Days | 0.25 |
| Moving Average 200 Days | 0.58 |
| Change | 0.01 |
Data not available
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
GlobeNewswire Inc.
Sep 04, 2025 12:01 PM GMT
RED BANK, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Tharimmune, Inc. (Nasdaq: THAR), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and critical unmet medical needs anno